.png){kind=icon}
Xcellate.技术套房
Xcellate.®is a suite of data and technology enabling solutions designed to increase drug and medical device development efficiency, reduce timelines, improve compliance, and drive commercialization.
SERVICES
Data and Technology
Covance利用无与伦比的专有数据和技术来改善临床研究结果。
By the Numbers
网站激活病人
4.2
Months Faster vs. The Industry Oncology - Global - Phase I-IV
招聘率
14%
更快的与行业肿瘤学 - 全球阶段I-IV
Screen Failure
26%
较少的与行业肿瘤学 - 全球阶段I-IV
Patient Density
63%
Better vs. The Industry Cardiology - Global - Phase I-IV
FEATURED WEBINAR
Measuring Success of a Quality Risk Management Approach
As regulatory guidance and data collection in clinical trials has evolved, sponsors face pressure to balance quality, productivity and cost for risk management and monitoring. The industry has adopted risk-based quality management (RBQM), yet the methodology is inconsistent. There is no standard way to measure the impact of the different approaches to RBQM on the effectiveness of clinical trial management. Learn more about our approach to establishing and tracking metrics – including those that could apply across the industry – to measure the success of an RBQM approach.
TESTIMONIAL
“市场上的没有人有这种洞察力与为什么患者会/不会加入临床试验。这是一种差异化的销售和极其创新性。”
–VP, Top 5 Pharma
景is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.